.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Desmopressin acetate - Generic Drug Details

« Back to Dashboard
Desmopressin acetate is the generic ingredient in nine branded drugs marketed by Apotex Inc, Sun Pharm Inds, Hospira, Ferring Pharms Inc, Impax Labs Inc, Bausch And Lomb, Glenmark Pharms Ltd, Ferring, Mylan Pharms Inc, Csl Behring, Actavis Labs Fl Inc, Sun Pharma Global, Bedford, Sun Pharm Inds Ltd, and Teva Pharms Usa, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for desmopressin acetate. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: desmopressin acetate

Tradenames:9
Patents:0
Applicants:15
NDAs:21
Drug Master File Entries: see list19
Suppliers / Packaging: see list22
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Formulation / Manufacturing:see details
Drug Prices:see low prices

Clinical Trials for: desmopressin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring
CONCENTRAID
desmopressin acetate
SOLUTION;NASAL019776-001Dec 26, 1990DISCNNo
Glenmark Pharms Ltd
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL201831-002May 28, 2015RXNo
Mylan Pharms Inc
DESMOPRESSIN ACETATE
desmopressin acetate
TABLET;ORAL200653-002Jun 27, 2014RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: desmopressin acetate

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
SOLUTION;NASAL017922-001Approved Prior to Jan 1, 19825,763,407<disabled>
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 19955,674,850<disabled>
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-002Apr 25, 19955,500,413<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc